OpenVSafe by OpenVAERS
Search V-safe

7W8-31335-17114

2 vaccinations 7 coded responses 19 check-ins 7 free-text entries 0 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
773 / TX
Registered
2021-03-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-04
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-05
    Registered in v-safe
  3. 2021-03-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-03-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-03-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-09
    Survey response — days 1–6 daily, dose 1
    MedDRA: Fatigue, Pre-existing disease — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: I have multiple comorbidities that could count for fatigue.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Fatigue — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: I have medical conditions that make me fatigued.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-11
    Survey response — day 7, dose 1
    MedDRA: Fatigue — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: I have other conditions that make me tired.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-18
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-03-25
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-03-27
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood pressure increased — Feeling: Fair · Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Blood pressure issues: crisis level when standing; dangerous when seated and elevated when laying down
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Condition aggravated, Erythema, Feeling hot, Flushing, Pre-existing disease, Swelling face — Feeling: Fair · Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Have red hot facial swelling and flushing due to MCAS flare
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-04
    Survey response — day 7, dose 2
    MedDRA: General symptom, Pre-existing disease — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: I have comorbidities that can account for these symptoms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-10
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-04-17
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  18. 2021-04-24
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  19. 2021-05-02
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-05-08
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  21. 2021-09-25
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2022-03-27
    Survey response — 12 months, dose 2
    MedDRA: Fatigue, Migraine, Orthostatic hypotension, Vertigo — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Vertigo, migraines, fatigue, orthostatic hypotension
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-04Pfizer-BioNTech
22021-03-27Pfizer-BioNTech

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-09

Systemic reaction (other): I have multiple comorbidities that could count for fatigue.

2021-03-10

Systemic reaction (other): I have medical conditions that make me fatigued.

Release 5 — day 7, dose 1

2021-03-11

Systemic reaction (other): I have other conditions that make me tired.

Release 6 — days 1–6 daily, dose 2

2021-04-01

Systemic reaction (other): Blood pressure issues: crisis level when standing; dangerous when seated and elevated when laying down

2021-04-02

Systemic reaction (other): Have red hot facial swelling and flushing due to MCAS flare

Release 6 — day 7, dose 2

2021-04-04

Systemic reaction (other): I have comorbidities that can account for these symptoms

Release 11 — 12 months, dose 2

2022-03-27

Symptoms: Vertigo, migraines, fatigue, orthostatic hypotension

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue · · ✓
SDMigraine · · ✓
SDOrthostatic hypotension · · ✓
SDVertigo · · ✓
SROBlood pressure increased ✓ ✓ ✓
SROCondition aggravated ✓ ✓ ✓
SROErythema ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROFeeling hot ✓ ✓ ✓
SROFlushing ✓ ✓ ✓
SROGeneral symptom ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROSwelling face ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release